gastroparesis from glp 1 New data links GLP-1 agonists for weight loss with higher risk for pancreatitis, GI events GLP-1 Drugs And Gastroparesis: What

However, others showed that daily administration of a peptide antagonist for one week enhanced weight gain and food intake in diet-induced obese mice (95)

Eleven large CVOTs have investigated the impact of GLP-1RAs on major adverse cardiovascular events (MACE) defined as a composite of CV death, nonfatal MI, and nonfatal stroke or on maximum walking distance in peripheral artery disease (57, 58)

Zhang, F

Data suggest that GIP worsens insulin sensitivity through effects on cytokine production [12] in adipose tissue [13]

Members who completed or claimed under the prior guarantee before June 10, 2026 are not affected by the transition

11,12 While use of GLP-1RA for cardiovascular benefits has been increasing, whether GLP-1RA can be used for arrhythmia prevention remains unknown because none of cardiovascular outcome trials for GLP-1RA studied AF as a primary outcome